Physician profile
Amy Votta
NPI 1053422550
$2,157.60
in general payments reported to CMS, 2019-2025
22 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $759 · 2022: $338 · 2023: $189 · 2024: $358 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.95 |
| Education | $165.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $356.89 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $322.59 | 2021-2025 | Annovera |
| Exeltis, USA INC. | $215.93 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $182.96 | 2024-2025 | Veozah |
| Millicent US INC | $163.37 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Pfizer INC. | $140.74 | 2021-2023 | |
| Axonics, INC. | $114.30 | 2021 | |
| Therapeuticsmd, INC. | $110.49 | 2021-2022 | |
| Avion Pharmaceuticals | $95.41 | 2022-2023 | Divigel, Balcoltra |
| Hologic Sales and Service, LLC | $93.19 | 2021-2025 | Aptima |
| Myovant Sciences INC. | $66.06 | 2021-2022 | |
| Agile Therapeutics, INC. | $62.75 | 2021-2023 | Twirla |
| Evofem Biosciences, INC. | $53.30 | 2021 | |
| Currax Pharmaceuticals LLC | $38.69 | 2021-2022 | |
| Acella Pharmaceuticals, LLC | $30.11 | 2024 | NP Thyroid 60 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23.96 | 2024 | Trintellix |
| Organon LLC | $15.94 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $15.72 | 2022 | |
| Radius Health, INC. | $15.53 | 2022 | |
| Shield Therapeutics INC | $14.38 | 2023 | Accrufer |
| Lupin INC. | $13.05 | 2021 | |
| Coopersurgical, INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Votta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.